© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

SRI

Top section

Top section

Adnoc expands sustainable financing with $2bn green loan

The company's new loan is backed by a Korean export credit agency
By backing too many speculative IPOs, investment banks could threaten the whole market
SSA

IDB Invest becomes first MDB to tap its securitization

$450m add-on makes deal more efficient

Finland's YIT signs €200m SLL and amends term loan

Company retains same roster of banks that provided last loan
By backing too many speculative IPOs, investment banks could threaten the whole market
Sub-sections
  • The rise in US Treasury yields in reaction to the government's $1.9tr stimulus package has prompted a shift in equity markets away from highly valued tech stocks that may do less well if interest rates rise as a result of higher inflation. But if the switch means investor portfolios reflect the wider economy, that is a positive development.
  • China’s YishengBio is planning to list in Hong Kong, having filed an IPO application with the bourse on Monday.
  • SK Bioscience has priced its IPO at the top of the marketed range, raising W1.49tr ($1.32bn) from South Korea’s largest listing in four years.